ANBITION is a startup focused on providing solutions for angiogenesis, pathological angiogenesis, anti-angiogenic therapy, and synthetic peptides. Founded in 2018, the company operates in the Health Care and Health and Wellness industries. Despite a lack of specific information regarding its headquarters, ANBITION offers inquiries through phone calls and emails. As of now, there is no public record of any external investments in the company. This sector holds great potential for growth, and ANBITION's innovative approach to tackling issues within this space positions the company as an intriguing prospect for potential investors.
There is no investment information
No recent news or press coverage available for ANBITION.